Safety Rates Drug Report: adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

Drug Injury Quarter

Person who experienced the adverse event (patient)

Event ID	CASEID	CASEVERSION	I F COD	EVENT DT	MFR DT	INIT FDA DT	FDA DT	REPT COD	AUTH NUM	MFR NUM	MFR SNDR	LIT REF	AGE	AGE COD	AGE GRP	GNDR COD	E SUB	WT	WT COD	REPT DT	TO MFR	OCCP COD	REPORTER COUNTRY	OCCR COUNTRY
125391451	12539145	1	I	20160418	20160525	20160708	20160708	EXP		DE-ROCHE-1767117	ROCHE		86.00	YR		F	Y	0.00000		20160708		MD	DE	DE

Drug(s) used by person

Event ID	CASEID	DRUG SEQ	ROLE COD	DRUGNAME	PROD AI	VAL VBM	ROUTE	DOSE VBM	DECHAL	LOT NUM	NDA NUM	DOSE AMT	DOSE UNIT	DOSE FORM	DOSE FREQ
125391451	12539145	1	PS	LUCENTIS	RANIBIZUMAB	1	Other	0.5 MG, UNK	U	S2012S,S2012B,S2011F	125156	.5	MG	SOLUTION FOR INJECTION
125391451	12539145	2	SS	LUCENTIS	RANIBIZUMAB	1	Other	0.5 MG, UNK	U	S2012S,S2012B,S2011F	125156	.5	MG	SOLUTION FOR INJECTION
125391451	12539145	3	SS	LUCENTIS	RANIBIZUMAB	1	Other	0.5 MG, UNK	U	S2012S,S2012B,S2011F	125156	.5	MG	SOLUTION FOR INJECTION
125391451	12539145	4	C	GLIMEPIRID	GLIMEPIRIDE	1	Oral	2 MG, QD			0	2	MG		QD
125391451	12539145	5	C	RAMIPRIL HCT	HYDROCHLOROTHIAZIDERAMIPRIL	1	Oral	12.5/5 MG, QD			0	1	DF		QD

Indications of drugs used

Event ID	CASEID	INDI DRUG SEQ	INDI PT
125391451	12539145	1	Neovascular age-related macular degeneration
125391451	12539145	4	Diabetes mellitus
125391451	12539145	5	Hypertension

Outcome of event

Reactions reported

Event ID	CASEID	PT
125391451	12539145	Retinal detachment
125391451	12539145	Retinal tear
125391451	12539145	Retinopathy proliferative

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

no results found

Therapies reported

Event ID	CASEID	DSG DRUG SEQ	START DT	END DT
125391451	12539145	1	20150129
125391451	12539145	2	20150226
125391451	12539145	3	20150326	20150326